- Report
- August 2019
- 30 Pages
China
From €1963EUR$2,200USD£1,687GBP
- Report
- August 2018
- 21 Pages
Global
From €8924EUR$10,000USD£7,670GBP
- Report
- July 2018
- 30 Pages
China
From €1963EUR$2,200USD£1,687GBP
- Report
- April 2018
United States
From €7135EUR$7,995USD£6,132GBP
- Report
- September 2026
Global
From €3561EUR$3,990USD£3,060GBP
- Report
- September 2026
China
From €3561EUR$3,990USD£3,060GBP
- Report
- September 2026
United States
From €3561EUR$3,990USD£3,060GBP
- Report
- September 2026
North America
From €3561EUR$3,990USD£3,060GBP
- Report
- September 2026
Europe
From €3561EUR$3,990USD£3,060GBP
- Report
- September 2026
Middle East
From €3561EUR$3,990USD£3,060GBP
- Report
- September 2026
Asia Pacific
From €3561EUR$3,990USD£3,060GBP
- Report
- September 2026
Europe
From €3561EUR$3,990USD£3,060GBP
- Report
- February 2026
- 86 Pages
Russia, India, China, ... Russia, India, China, Brazil
From €5350EUR$5,995USD£4,598GBP
- Report
- February 2026
- 109 Pages
Asia Pacific
From €5350EUR$5,995USD£4,598GBP
- Report
- February 2026
- 29 Pages
Mexico
From €4458EUR$4,995USD£3,831GBP
- Report
- February 2026
- 29 Pages
Brazil
From €4458EUR$4,995USD£3,831GBP
- Report
- February 2026
- 29 Pages
Japan
From €4458EUR$4,995USD£3,831GBP
- Report
- February 2026
- 34 Pages
China
From €4458EUR$4,995USD£3,831GBP
- Report
- February 2026
- 29 Pages
South Korea
From €4458EUR$4,995USD£3,831GBP
- Report
- February 2026
- 29 Pages
Russia
From €4458EUR$4,995USD£3,831GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more